Latest

The day's market news, with the argument attached

New notes every trading day on earnings, policy and market structure. Each one opens with the conclusion, then the evidence, then the companies it hits.

What Big Funds Own22 fundsWhat Berkshire, Bridgewater and other big funds reported holding last quarter.What Analysts Expect16 stocksRatings and price targets from the big institutions, each with its public source.

2026-08-19

Estée Lauder's fragrance forecast vs. Lowe's and Target: premium beauty is showing up as the cleanest “American consumer split” signal insight cover

Earnings

Aug 19, 2026

EL · LOW•8 min read

Estée Lauder's fragrance forecast vs. Lowe's and Target: premium beauty is showing up as the cleanest “American consumer split” signal

On the same earnings day that Lowe's guided conservatively, Estée Lauder framed fiscal 2027 as a resilience test where fragrance is still delivering and adjusted operating margin can approach 13%. The result is an unusually sharp divergence: premium self-care is buying time with pricing power while mass retail is leaning on policy tailwinds and project pullbacks—exactly the bifurcation investors keep seeing in US spend data.

Fiscal 2027 net sales growth (preliminary view): 3%–5%Fiscal 2027 adjusted operating margin (prelimina: 12.5%–13.0%

Etched’s $21B jump signals that inference silicon is moving from “experiment” to “economics”—and it pressures Nvidia’s GPU advantage on both cost and capacity

Etched’s Aug. 18 financing valued the company at $21B after a prior $10.3B valuation just weeks earlier—an investor re-rate that coincides with first customer delivery to Jane Street and more than $1B in customer contracts. The market takeaway is not “another chip startup,” but a shift toward dedicated inference hardware that competes with GPUs on two fronts: utilization/cost per token and rack-level capacity to meet urgent decoding demand.

Aug. 18 financing: $700MAug. 18 implied valuation: $21B

Fed minutes lean hawkish while the Treasury scales buybacks—September becomes a tug-of-war between inflation control and fiscal support

The latest FOMC minutes underscore a conditional path to rate firming if inflation stays elevated, with policymakers explicitly linking “some policy firming” to inflation scenarios. At the same time, the Treasury announced a doubled scale for certain debt buyback operations, supporting market liquidity and pushing yields lower—so September is set to be decided by which transmission mechanism dominates first.

Event Date: 2026-08-19Topic Type: Markets / Event

Read article

Haemonetics HAE just locked CSL CSLLY into a plasma-collection device flow—without exclusivity. The stock jump is the market betting the “bottleneck” is CSL’s capacity, not Haemonetics’ supply. insight cover

Industry News

Aug 19, 2026

HAE · CSLLY•7 min read

Haemonetics HAE just locked CSL CSLLY into a plasma-collection device flow—without exclusivity. The stock jump is the market betting the “bottleneck” is CSL’s capacity, not Haemonetics’ supply.

Haemonetics HAE formalized an expanded, non-exclusive plasma-collection supply agreement with CSL CSLLY that lets CSL use Haemonetics’ NexSys PCS devices with Persona PLUS technology and buy related disposables in the U.S., with no minimum purchase commitments. The deal shifts the adoption test to CSL’s collection-center transition plan—exactly where plasma liquidity is structurally constrained—explaining why investors treated the announcement as a high-signal catalyst.

Agreement entry date: Aug 14, 2026Commercial scope: U.S.

Home Depot’s Q2 beat held up—but the ‘Pro mix at the housing turn’ story faces a tougher tell: transactions fell as ticket pressure did

In The Home Depot’s Aug. 18 release for Q2 FY2026, comparable sales rose 1.7% while transactions declined 1.0% and average ticket was down 2.8%—a profile that can look like cautious demand rather than a clear Pro-led housing bottom. Until Home Depot discloses Pro/customer-mix granularity in its next materials, the strongest signal for investors is less about a “housing rebound now” and more about whether management can stabilize transaction counts while protecting gross margin near 33.1%.

Comparable sales (Q2 FY2026): Up 1.7%U.S. comparable sales (Q2 FY2026): Up 1.3%

JBS tried to buy out Pilgrim’s Pride at a $26.50 cash price—then withdrew after the special committee rejected the valuation

JBS’s unsolicited squeeze-out attempt for the remaining minority holders of Pilgrim’s Pride centered on a $26.50-per-share cash offer (later raised to $28.50). The deal didn’t close because Pilgrim’s Pride’s special committee judged the price as not appropriately valuing non-JBS shareholders’ stake, and JBS ultimately withdrew the proposal in February 2022—turning the episode into a live test of poultry-margin confidence versus minority-premium math.

Initial buyout price: $26.50Raised later: $28.50

Read article

J&J’s MONARCH QUEST 3 clearance targets early lung-cancer diagnosis—now the key question is whether it can out-pace Intuitive’s Ion on procedure yield insight cover

Industry News

Aug 19, 2026

ISRG · JNJ•7 min read

J&J’s MONARCH QUEST 3 clearance targets early lung-cancer diagnosis—now the key question is whether it can out-pace Intuitive’s Ion on procedure yield

Johnson & Johnson secured U.S. 510(k) clearance for MONARCH QUEST 3 on Aug. 17, 2026, positioning the software update to improve bronchoscopy planning, navigation, and targeting for earlier lung-cancer diagnosis. The near-term investor swing is whether faster, higher-yield biopsies translate into more reimbursed procedure volume in a market already served by Intuitive Surgical and its Ion platform—especially as Johnson & Johnson is also managing 2026 EPS drag from recent deals.

J&J 2026 EPS drag (deal-related): ≈$0.64J&J FY2025 EPS (reported): 11.03

La-Z-Boy’s tariff math vs. housing deferral: furniture kept moving, but margins told you tariffs weren’t fully “refunded”

In La-Z-Boy’s fiscal Q1 FY2027 results filed Aug. 18, 2026, the company reported consolidated revenue down 3.4% year over year, while retail delivered sales growth. The most investor-relevant signal wasn’t just “demand held up”—it was that favorable tariff effects raised gross margin by ~140 bps, yet operating profit collapsed due to wholesale volume and fixed-cost deleverage.

Consolidated revenue: $475.7MWholesale sales (external): $218.8M

Lyntris’ downsized IPO isn’t a pricing story—it’s a backlog-to-execution test defense investors are failing faster

Lyntris LYNX priced its U.S. IPO at $17.50 and raised about $297.5 million, after targeting a much larger deal at $19–$22. The move spotlights a tightening “proof over narrative” filter in defense capital formation: investors are discounting situations where big backlog and upbeat contracts don’t translate cleanly into realized revenue and margin.

IPO price: $17.50Marketed price range: $19–$22

Read article

Moderna’s cancer-vaccine readout puts mRNA oncology on the board—and forces Merck’s pipeline economics to re-rate insight cover

Industry News

Aug 19, 2026

MRNA · MRK•9 min read

Moderna’s cancer-vaccine readout puts mRNA oncology on the board—and forces Merck’s pipeline economics to re-rate

A Merck–Moderna personalized mRNA cancer vaccine program has produced a positive, late-stage signal in high-risk melanoma, shifting investors from “platform hope” to “repeatable oncology engine.” The immediate implication is not just upside for Moderna: it also changes how Merck & Co. has to think about the probability-weighted value of personalized mRNA add-ons to KEYTRUDA across the pipeline—and how manufacturing capacity will gate commercial timing.

RFS impact (vs KEYTRUDA alone): HR 0.51Risk reduction (RFS): 49%

Pennsylvania turns AI data-center approvals into a consent-gated process—ending the “buy gas rights” shortcut and reshuffling who can finance fast buildouts

Pennsylvania’s Aug. 18, 2026 executive order makes AI data-center permitting in the state conditional on executing enforceable GRID commitments and proving local approvals for projects above 25 MW. The change directly challenges the economics of “permit-by-power-queue bypass” strategies, where developers secured fuel rights while waiting behind grid and permitting constraints.

Order signature date: Aug. 18, 2026Immediate effect: Immediate

Rocket Lab’s $981M Space Force “vehicle onboarding” is a backlog lever—because its accounting turns eligible bids into contract liabilities, not just headline awards

Rocket Lab RKLB was onboarded to the U.S. Space Force’s $981M NITE-STAR IDIQ contract vehicle on Aug. 18, which makes it eligible for task orders up to the program’s ceiling. Unlike a direct award-to-revenue event, onboarding changes the odds that future work enters backlog/contract liabilities—and Rocket Lab’s current segment economics show why winning more “Space Systems” work matters for margin mix while Launch remains more execution-sensitive.

Backlog (end of period): $2.356BBacklog timing: 45% / 55%

The SEC’s “Regulation Crypto Assets” proposal turns crypto compliance into a licensing ladder—with custody-and-bank intermediaries positioned to win faster than token-market sentiment

On Aug. 18, 2026, the SEC proposed “Regulation Crypto Assets,” a tailored securities offering framework that adds a conditional safe harbor plus two registration exemptions for certain crypto investment contracts. The immediate market implication is less about token price direction and more about which intermediaries can (and will) operationalize offering disclosures and investor-protection controls—especially registered, custody-oriented financial firms.

Proposal announcement date: Aug. 18, 2026Regulation name: Regulation Crypto Assets

Target's “turnaround” look is improving, but the $-quality of the beat hinges on how much tariff money is truly flowing

Target’s latest reported quarter shows a clear EPS upswing, but the company also flags tariff-refund uncertainty (and explicitly says any received amounts have been immaterial). The investor question isn’t whether turnaround narrative is working—it’s whether gross margin and operating expense discipline are doing enough of the lifting versus one-time items that can’t be counted on.

Q2 FY2026 reported EPS: $4.13Q2 FY2026 revenue: $25.54B

TJX beat again—but Marmaxx weakness reads like a clearance-led warning, not a pure execution hiccup

In Q2 FY2027, TJX delivered above-plan results and raised full-year guidance, but its largest Marmaxx division reported below-expectations sales tied to “self-inflicted” merchandising execution issues. The key investor question isn’t whether Marmaxx can fix execution quickly—it’s whether softer performance at the off-price clearance channel is starting to signal less excess inventory in the supply chain and a more selective consumer.

Q2 FY2027 net sales: $15.18BQ2 FY2027 diluted EPS: $1.36

Toll Brothers just showed how new-home orders can run even when the “housing market is frozen” for resale buyers at ~6.7% mortgages

In its Q2 FY2026 reporting, Toll Brothers showed net signed contracts rising in units while backlog cancellations stayed in a controlled band—evidence that rate sensitivity is being managed through pricing/mix, pacing, and land planning rather than collapsing demand. That helps sharpen the investor question: does a “frozen” resale backdrop automatically freeze new-home demand, or do builders decouple via incentives, buyer quality, and build-cycle timing?

Contracted homes: 2,834Net signed contract value: $2.81B

Treasury’s doubled debt buybacks look like quasi-QE—but the mechanism is closer to plumbing support than term-premium math

The U.S. Treasury’s Aug 18–19 decision to double its debt buyback program is a direct liquidity backstop for specific off-the-run Treasury issues, not a broad-based asset purchase like 2020’s QE. For rates investors, the key question is whether tighter bid/offer spreads and fewer dealer balance-sheet constraints can suppress term-premium moves—or merely redistribute trading flows across the auction calendar while yields reprice.

10-year yield context: Mid-4% levelsOperational form: Off-the-run nominal coupon + TIP

UAE cuts Iran off financially and commercially: the Gulf’s “re-export valve” closing risks war-risk shipping, gold logistics, and credit flows

On Aug 19, the UAE suspended all financial and economic transactions with Iran after a reported missile incident involving Iran, according to Reuters. The move matters beyond crude: it changes Iran’s import logistics through the UAE’s re-export and payment channels and can quickly re-price war-risk shipping and associated insurance terms across the Strait of Hormuz, which can also feed through to near-term gold flows.

Event Date: 2026-08-19Topic Type: Markets / Event

Unitree’s 5x Shanghai debut turns China’s humanoid supply chain into a capital magnet—here’s who captures the first funding windfall

Unitree Robotics (listed as Yushu Technology) debuted on Shanghai’s STAR Market after an IPO priced at 150.8 yuan—then opened at 1,100 yuan, implying a ~5–6x first-day jump versus the offer. The windfall is likely to flow first into the “mechanics layer” (actuators, harmonic reducers, precision sensing) because Unitree’s IPO disclosed near-term R&D and manufacturing-capex use of proceeds—while US-led procurement barriers can redirect Chinese demand into domestic component ecosystems that Tesla Optimus can’t easily bypass.

IPO offer price: 150.80 yuanOpened on debut: 1,100 yuan

Crossing $40T Turns Treasury Buybacks Into an Accounting Puzzle at ~4.65% 10-Year Yields

When U.S. debt tops $40 trillion while the 10-year sits near 4.65%, interest-cost arithmetic starts working against any “stabilize liquidity” debt buyback plan. The key contradiction isn’t that buybacks are useless—it’s that at today’s term yields, even modest net issuance can compound into a much faster rise in annual net interest, forcing a larger share of future fiscal space to be auctioned back to investors.

Net interest on the debt (FY2026-to-date): $931BNet interest on the debt (July 2026): $104B

Read article

What to expect

Evidence-first notes with a visible point of view.

This section collects sharp takes on earnings, shareholder meetings, and market structure. Each new piece should make the thesis, the facts, and the implications obvious within the first few screens.

Expect direct analysis, not generic commentary.

Expect the data to be explicit and the argument to be easy to follow.

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer